title: Telmisartan, ramipril, or both in patients at high risk of vascular events.
authors.forename: Franz H
authors.initials: FH
authors.lastname: Messerli
authors.forename: Sripal
authors.initials: S
authors.lastname: Bangalore
authors.forename: Venkata S
authors.initials: VS
authors.lastname: Ram
mesh_terms: D000799:Angioedema / Q000139:chemically induced; D047228:Angiotensin II Type 1 Receptor Blockers / Q000009:adverse effects*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D001562:Benzimidazoles / Q000009:adverse effects*; D001565:Benzoates / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D017257:Ramipril / Q000009:adverse effects*; D000077333:Telmisartan
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D001562:Benzimidazoles; D001565:Benzoates; D017257:Ramipril; D000077333:Telmisartan